S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSEAMERICAN:MAIA

MAIA Biotechnology (MAIA) Stock Price, News & Analysis

$2.20
-0.28 (-11.29%)
(As of 03/28/2024 ET)
Today's Range
$2.15
$2.51
50-Day Range
N/A
52-Week Range
$0.82
$4.25
Volume
354,822 shs
Average Volume
442,375 shs
Market Capitalization
$31.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MAIA Biotechnology MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
4.23% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.49mentions of MAIA Biotechnology in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$200,000 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.47 out of 5 stars

MAIA stock logo

About MAIA Biotechnology Stock (NYSEAMERICAN:MAIA)

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

MAIA Stock Price History

MAIA Stock News Headlines

$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
See More Headlines
Receive MAIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MAIA Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2023
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:MAIA
CIK
N/A
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Net Income
$-19,770,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.03 per share

Miscellaneous

Free Float
6,116,000
Market Cap
$31.26 million
Optionable
Not Optionable
Beta
0.16
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

MAIA Stock Analysis - Frequently Asked Questions

Are investors shorting MAIA Biotechnology?

MAIA Biotechnology saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 508,500 shares, an increase of 30.8% from the February 29th total of 388,800 shares. Based on an average daily volume of 424,500 shares, the short-interest ratio is currently 1.2 days. Approximately 4.2% of the shares of the stock are short sold.
View MAIA Biotechnology's Short Interest
.

How were MAIA Biotechnology's earnings last quarter?

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) posted its earnings results on Monday, May, 8th. The company reported ($0.38) EPS for the quarter, topping analysts' consensus estimates of ($0.40) by $0.02.

Who are MAIA Biotechnology's major shareholders?

MAIA Biotechnology's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.23%), Vanguard Group Inc. (1.23%), Bridgeway Capital Management LLC (0.53%) and Citadel Advisors LLC (0.40%). Insiders that own company stock include Cristian Luput, Joseph F Mcguire, Ramiro Guerrero, Stan Smith and Vlad Vitoc.
View institutional ownership trends
.

How do I buy shares of MAIA Biotechnology?

Shares of MAIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:MAIA) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners